$26.93
0.100.37%
Last update: Nov 6, 11:21 AM
Adaptive Biotechnologies Corp (ADPT) Stock Price, Quote, News & History
ADPTNASDAQ
Adaptive Biotechnologies (NASDAQ:ADPT) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has...
You can purchase shares of Adaptive Biotechnologies (NASDAQ:ADPT) through any online brokerage.
Other companies in Adaptive Biotechnologies’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Adaptive Biotechnologies has a consensus price target of $23.95.
The stock price for Adaptive Biotechnologies (NASDAQ: ADPT) is $26.93 last updated November 6, 2026 at 11:21 AM EST.
There are no upcoming dividends for Adaptive Biotechnologies.
Adaptive Biotechnologies does not have any upcoming earnings scheduled.
There is no upcoming split for Adaptive Biotechnologies.
Adaptive Biotechnologies is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ,...
